Roche gets FDA approval for all‑in‑one respiratory virus test
Roche says the launch will help labs and clinics prepare for a busy respiratory virus season, when COVID-19, flu, and RSV often spread simultaneously.
Roche says the launch will help labs and clinics prepare for a busy respiratory virus season, when COVID-19, flu, and RSV often spread simultaneously.
NRF Executive Vice President of Government Relations David French urged the administration to pursue “binding trade agreements that truly open markets by lowering tariffs, not raising them.”
While most industries struggle, health care continues to hire, but tariffs could test its resilience.
Equipped with advanced automation and temperature-controlled storage, the center is designed to fill and deliver prescriptions within hours.
“If you refuse to step up, we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices.”
New research reveals a significant gap between what beauty retailers think shoppers want and what they actually expect when they enter a store.
The pilot will assess program feasibility, patient nutrition security, clinical outcomes like A1c and blood pressure, and sustainability with health plan partners.
The company emphasized it has “full confidence in its practices” and is “committed to working cooperatively” with federal investigators.
The Swiss drugmaker is in active discussions with the U.S. government regarding a plan that could eliminate middlemen, such as pharmacy benefit managers (PBMs).
A highlight was the presentation of the 2025 Good Neighbor Pharmacy Champion Awards, recognizing three member pharmacies for leadership in advocacy, clinical care, and patient engagement.
Facts up Front is a voluntary, industry-led initiative that displays key nutrition data from the FDA-required Nutrition Facts panel on the front of food and beverage packaging.
GLP-1 inhibitors linked to reduced mortality and fewer cognitive problems after stroke and brain hemorrhage, according to three studies.
Prescription drug spending overall increased by 8% last year, with Mercer projecting a 5.8% rise in total health benefit costs for 2025.
Although smaller, Neighborhood Markets still offer essential groceries and household items for daily needs.
The paper concludes that, although the negotiation program might reduce drug costs initially, it could threaten the long-term sustainability of the generics and biosimilars market, a key driver of lower prescription costs.
From beauty, anti-aging, natural foods, to wellness tourism, consumers prioritize health, sustainability, and transparency in their buying decisions.